Infection Prevention & Control Program

A complete F-880 §483.80(a)(1)–(4) Infection Prevention and Control Program (IPCP) policy plus survey-ready documentation tools for skilled nursing facilities. This template covers the IP leader designation, the facility-wide IPCP committee structure, the surveillance and outbreak response workflow, the line list and exposure tracking process, the linkage to antibiotic stewardship (forward-referenced to F-882), standard precautions and transmission-based precautions, the QAPI integration required by §483.80(a)(4), and the surveyor-encounter workflow CMS uses under F-880.

F-880 is one of the highest-volume citations in the CMS scope-and-severity grid. Under 42 CFR §483.80(a)(1), the facility must establish an IPCP under the direction of a qualified IP professional. Under §483.80(a)(2), the program must include written standards, policies, and procedures for the surveillance, prevention, and control of healthcare-associated infections and communicable diseases. Under §483.80(a)(3), the program must include an antibiotic stewardship program component (forward-referenced to F-882). Under §483.80(a)(4), the program must be reviewed and updated annually and integrated into the facility QAPI program. Surveyors treat a break at any of the four legs as a citation trigger, and surveyors will test the program across the full facility on Day 1 of survey.

The most common F-880 citation patterns documented across recent CMS citation data include: no designated qualified IP leader (or no documentation of qualifications), IPCP standards that exist on paper but are not operationalized on the resident unit, surveillance that records infections but does not drive intervention, outbreak response that lacks a documented line list and exposure tracking, no documented linkage between infection events and antibiotic use, no annual program review or QAPI integration, and inconsistent standard-precaution or transmission-based-precaution compliance observable on rounds. This template gives the Infection Preventionist (IP), the Director of Nursing, the Staff Development Coordinator, and the NHA a single shared workflow so that designation, surveillance, intervention, outbreak response, antibiotic stewardship linkage, and QAPI integration all generate a defensible paper trail.

CMS guidance (State Operations Manual, Appendix PP, F-880) treats the IPCP as a substantive obligation that operates in real time, not a binder of policies reviewed annually. The surveyor will trace a sampled infection event from initial recognition through line list entry through intervention and antibiotic review through resolution, and any gap in that chain is a citation. Surveyors also observe standard precaution compliance on rounds and will cite F-880 when hand hygiene, PPE use, injection safety, point-of-care device cleaning, or environmental cleaning are observed to be out of compliance. This template closes that chain at each step.

This template is intended for use by the Infection Preventionist (IP), the Director of Nursing, the Staff Development Coordinator, the attending physicians for orders tied to isolation, diagnostic testing, and treatment, the consultant pharmacist for the antibiotic stewardship linkage, the maintenance/environmental services lead for environmental cleaning, and the QAPI committee for program review and integration. The IP retains operational accountability for program execution. The DON retains nursing accountability for resident-care adherence. The administrator retains accountability for the staffing and resource support required to operate the program. The included surveyor-encounter sheet should be walked at minimum 30 days before any anticipated survey window.

Purpose

The purpose of this policy is to establish a single, defensible, surveyor-reviewable Infection Prevention and Control Program under 42 CFR §483.80(a)(1)–(4). It defines IP designation and qualifications, program committee structure, surveillance methodology and triggers, line list management, outbreak response workflow, standard precautions and transmission-based precautions, antibiotic stewardship linkage, QAPI integration, and the documentation chain required to demonstrate that the facility both operates the IPCP in real time and meets all four regulatory legs of the requirement.

Policy

The facility shall maintain an Infection Prevention and Control Program that meets the requirements of 42 CFR §483.80(a)(1)–(4). The program shall be directed by a qualified Infection Preventionist with documented training and qualifications in infection prevention and control. The program shall include written standards, policies, and procedures for surveillance, prevention, and control of healthcare-associated infections and communicable diseases that comply with accepted national standards (CDC/HICPAC, APIC, SHEA, or comparable). The program shall include an antibiotic stewardship component that meets F-882. The program shall be reviewed and updated at least annually and shall be integrated into the facility QAPI program under §483.75.

Scope

This policy applies to all residents admitted to the facility for skilled nursing or long-term care, regardless of payer source, diagnosis, or infection risk profile. It applies to all clinical, environmental, ancillary, contracted, and volunteer staff whose work brings them into contact with residents or the resident environment, including but not limited to: registered nurses, licensed practical nurses, certified nursing assistants, attending physicians, the consultant pharmacist, therapists, dietary staff, housekeeping and environmental services staff, maintenance staff, activities staff, social workers, the IP, the DON, the Staff Development Coordinator, the NHA, and any contracted laboratory or radiology staff. The policy applies during routine operations, during outbreaks, during transitions of care, during episodes of suspected infection, and during any period in which a communicable disease exposure is identified or reasonably foreseeable.

Procedure

Infection Preventionist designation and qualifications

The facility shall designate a qualified Infection Preventionist (IP) who has primary professional training in nursing, medical technology, microbiology, epidemiology, or another related field, and who has completed specialized training in infection prevention and control. Acceptable qualifications include: completion of a CDC, APIC, or SHEA training course; certification as a CIC (Certified in Infection Control) or a-IPC; or demonstrated equivalent competency via documented supervised experience. The IP shall have dedicated time, authority, and support to operate the program. The designation shall be documented in a written appointment, with qualifications, date of designation, and role responsibilities attached to the appointment. The IP shall report to the administrator and shall have direct access to the DON, the attending physicians, and the QAPI committee.

Surveillance methodology and triggers

The IP shall operate a facility-wide infection surveillance system that identifies, tracks, and analyzes healthcare-associated infections and communicable disease events. Surveillance shall use standardized case definitions (CDC NHSN long-term care definitions or McGeer criteria) applied consistently. Surveillance triggers shall include, at minimum: positive laboratory cultures (blood, urine, sputum, wound, stool), antibiotic starts and changes, fever or clinically significant vital sign changes, clinical documentation of suspected infection, transfer to acute care for sepsis or infection-related diagnosis, and any reportable communicable disease. Surveillance shall be documented in a line list that is current at least weekly.

Line list and exposure tracking

The IP shall maintain a current line list of all suspected and confirmed infection events and all communicable disease exposures. The line list shall include, for each event: resident identifier, date of recognition, suspected source, clinical presentation, cultures obtained, antibiotics started or changed, isolation status, line list entry date, and resolution date. External exposures (new admissions from hospitals with active colonization, visitor or staff exposures, shared equipment exposures, interfacility transfer exposures) shall be tracked separately with documented follow-up for the full incubation window of each pathogen of concern. The line list shall be available to the surveyor within minutes of the request.

Outbreak response

The IP shall operate a documented outbreak response workflow. An outbreak is defined as an increase above baseline of a specific pathogen or syndrome in a defined resident population or geographic area over a defined time window, using the facility's outbreak definition thresholds. Outbreak response shall include: immediate line list expansion, immediate notification of the DON and administrator, immediate implementation of transmission-based precautions appropriate to the suspected pathogen, immediate notification of the local public health authority as required, immediate review of infection control practices in the affected unit(s), immediate review of antibiotic use in the affected population, and a documented post-outbreak after-action review within 30 days of resolution. The after-action review shall be retained in the survey binder.

Operational elements

Standard precautions

Standard precautions shall be applied to every resident, every interaction, every time, regardless of known or suspected infection status. Standard precautions include: hand hygiene before and after resident contact (or contact with the resident environment), use of appropriate PPE based on anticipated exposure, respiratory hygiene and cough etiquette, safe injection practices (one needle, one syringe, one time, for one resident), safe handling of sharps, environmental cleaning and disinfection of resident care equipment between uses, and proper handling of laundry and waste. Compliance shall be observed on rounds, documented through observation audits at minimum monthly, and addressed through in-service training when gaps are observed.

Transmission-based precautions

Transmission-based precautions (contact, droplet, airborne) shall be implemented immediately on clinical suspicion and prior to laboratory confirmation when the index of suspicion warrants. The decision to initiate, modify, or discontinue precautions shall be made by the IP in consultation with the DON and the attending physician. The decision and rationale shall be documented in the resident's medical record. Private room or cohorting shall be applied as available. Signage at the room entry shall identify the precaution type and the required PPE. The resident's care plan shall be updated to reflect the precaution status and any activity or dietary modifications required.

Antibiotic stewardship linkage

The IPCP shall operate in documented linkage with the antibiotic stewardship program (forward-referenced to F-882). Linkage shall include: shared review of every new antibiotic start by the consultant pharmacist with the IP notified, shared review of culture and sensitivity results at the time they return to the facility, shared line list and antibiotic use list reviewed at the QAPI committee, and shared participation by the IP in the monthly QAPI antibiotic use outcome review. The linkage shall be documented in meeting minutes and in the program policy cross-reference.

QAPI integration

The IPCP shall be integrated into the facility QAPI program under §483.75. Integration shall include: IP participation on the QAPI committee as a standing member, presentation of surveillance and outcome data at the QAPI committee at minimum monthly, performance of at least one PIP annually that is infection-related, documentation of program review and update annually with the QAPI committee, and documentation of any program change made in response to surveillance findings or PIP outcomes. The annual program review shall be retained in the survey binder.

Documentation

Documentation generated by this program shall include: the IP designation and qualifications; the IPCP policy and all program procedures; the surveillance methodology and definitions in use; the surveillance line list; the outbreak response records; standard precaution observation audits; transmission-based precaution initiation and discontinuation records; antibiotic stewardship linkage minutes; QAPI committee minutes documenting infection-related content; annual program review and update documentation; and the policy and procedure document itself. Documentation shall be retained per facility policy (commonly a minimum of one year for line list items and indefinitely for the policy itself) and shall be retrievable within surveyor timeframes.

Staff checklist

Charge nurse (RN/LPN) each shift: review new lab and culture results, identify any resident with suspected infection for IP notification, verify standard precaution compliance on rounds, verify isolation status matches precaution order for any resident on precautions. CNA each shift: perform hand hygiene before and after every resident contact, use PPE per standard or transmission-based precautions as ordered, report any infection-related observation to the nurse (new fever, cough, wound change, diarrhea). IP daily: review line list, review new antibiotic starts, review new culture results, communicate with DON and consultant pharmacist as indicated. IP weekly: present surveillance summary at clinical meeting, update line list and exposure tracking. DON monthly: review facility-wide infection patterns, ensure standard precaution observation audits are completed, ensure QAPI integration is current. NHA quarterly: review IPCP resource support and staffing alignment.

Surveyor-encounter sheet

When the surveyor requests F-880 documentation, the facility shall produce, in order: (1) the IPCP policy; (2) the IP designation and qualifications; (3) the surveillance methodology, definitions, and current line list; (4) any active outbreak response documentation and after-action reviews; (5) the standard precaution observation audits for the trailing 12 months; (6) the antibiotic stewardship linkage minutes; (7) the QAPI committee minutes documenting infection-related content; (8) the annual program review and update documentation; (9) any active transmission-based precaution records with initiation rationale; (10) the in-service training records for IP-related topics. The facility shall be ready to produce this documentation set within surveyor timeframes on Day 1 of survey, and shall maintain redundant retrievability through Day 3 and beyond.

Survey prep checklist

The IP and the DON shall complete a 30-day pre-survey F-880 audit covering: IP designation and qualifications currency; line list currency for the trailing 90 days (≥ 90% current per weekly review); standard precaution observation audit currency (≥ 90% of monthly audits completed); transmission-based precaution record completeness for any active precautions; antibiotic stewardship linkage documentation for any new antibiotic starts in the trailing 30 days; QAPI committee minutes currency with infection-related content; annual program review currency; outbreak after-action review currency for any outbreaks resolved in the trailing 12 months; and in-service attendance currency for IP-related topics. Identified gaps shall be documented with corrective action and a target completion date, and corrective action documentation shall be retained in the survey binder.

References

Primary regulatory authority: 42 CFR §483.80(a)(1)–(4) — Infection Prevention and Control Program. CMS State Operations Manual, Appendix PP — Guidance to Surveyors for Long Term Care Facilities, F-880 (cross-referencing F-882 for antibiotic stewardship). CDC/HICPAC and APIC guidelines on infection prevention and control in long-term care. SHEA position statements on long-term care infection prevention. CDC NHSN long-term care facility surveillance definitions and McGeer criteria. Facility QAPI program plan and annual review.